InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,528.00
(
0.90%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
0.00%
)
Bitcoin
69,471.62
(
-0.02%
)
Post# of 346542
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

goodJohnhunting

Send PM Follow Ignore
Followers 35
Posts 1202
Boards Moderated 1
Alias Born 08/27/2000

goodJohnhunting

Member Level

Re: newbieee post# 112307

Saturday, 02/16/2013 4:16:59 PM

Saturday, February 16, 2013 4:16:59 PM

Post# of 346542
Newbieee,

I've been concerned about tumor secreated exosomes, and the microRNA that they carry for months now. I'm not certain, but I suspect that the difference between Bavituximab being therapeutic in adenocarcinoma and not pancreatic cancer, is attributed to the difference in exosomes secreated between each malignancy.

The difference could be attributed to secreated microRNA and the distruction inflicted messenger proteins in pancreatic neoplasia. Maybe these secretions are not evident in adenocarcinoma (lung), or with less effect to Bavituximab's MOA?

There is a way to test this theory, and it's called "Immunohistochemistry", but what do I know? I'm just a shareholder...

All the best,
John

Disclaimer: Every post, and all my views are only speculative. Do not invest money or any other resources based on these post or opinions. Best of luck and do your own due diligence!

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM

Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!